RAB3A and non-small cell lung carcinoma: Protein mass spectrometry experiment, immunoprecipitation, immunofluorescence, subcellular fractionation, mitochondria isolation, cycloheximide assays, and lung cancer xenograft mouse models were performed to clarify the molecular mechanism of RAB3A in NSCLC progression.